07:00 , Apr 15, 2013 |  BC Week In Review  |  Company News

LifeCell other research news

LIFC received a $1 million grant from the U.S. Army Medical Research and Material Command to develop new tissue transplant products for use in surgery. The two-year agreement will cover the use of AlloDerm in...
07:00 , Apr 15, 2013 |  BC Week In Review  |  Company News

Integra LifeSciences Corp., LifeCell, Massachusetts Institute of Technology biomaterial/skin/wound news

IART and MIT filed suit in the U.S. District Court for the District of Massachusetts alleging that LIFC's AlloDerm acellular dermal graft infringes U.S. Patents Nos. 4,458,678 and 4,505,266 controlled by IART. The suit...
07:00 , Apr 15, 2013 |  BC Week In Review  |  Company News

LifeCell, Lifecore deal

LCBM's Lifecore Oral Restorative division (Chaska, Minn.) will exclusively distribute LIFC's AlloDerm in the U.S. The product is a processed human dermal cell-free matrix for periodontal applications, including free gingival grafts and guided bone...
08:00 , Jan 27, 2011 |  BC Innovations  |  Tools & Techniques

Fusion factor

Researchers at Massachusetts General Hospital have developed self-assembling nanoparticlesconsisting ofa fusion protein containing anelastin-like peptide and keratinocyte growth factor, two key components of skin remodeling.1 The nanoparticles could be a therapeutic option in indications like...
07:00 , Apr 14, 2008 |  BC Week In Review  |  Company News

LifeCell, Kinetic Concepts deal

Medical technology company Kinetic Concepts will acquire tissue engineering company LifeCell for $51 per share, or about $1.7 billion in cash. The price is an 18% premium to LifeCell's close of $43.15 on April 4,...
01:09 , Oct 18, 2005 |  BC Extra  |  Financial News

LifeCell reports revenues

LIFC reported preliminary third quarter product revenues of $24.3 million, up 62% from $14.9 million for the same quarter in 2004. The company also said it will record a $1.4 million charge in the third...
00:09 , Oct 8, 2005 |  BC Extra  |  Financial News

LifeCell falls on product recall

Tissue repair company LIFC dropped $2.40 (12%) to $17.75 on Friday after it recalled lots of three products because of concerns about a tissue supplier's donor documentation. LIFC recalled all lots of AlloDerm for use...
08:00 , Nov 11, 2002 |  BioCentury  |  Finance

Ebb & Flow

Cephalon (CEPH) and Shire (LSE:SHP; SHPGY) put an exclamation point to the end of biotech's third quarter earnings season. Both provided upside surprises, bringing to 14 the number of profitable biotechs that beat their Street...
08:00 , Mar 4, 2002 |  BioCentury  |  Finance

Ebb & Flow

Shire(LSE:SHP; SHPGY) is taking its lumps for making a conscious decision to invest in marketing at the expense of current earnings growth. SHP dropped 225p (30%) to 525p on the week after announcing that its...
08:00 , Feb 4, 2002 |  BC Week In Review  |  Company News

LifeCell, LifeNet deal

LifeNet, an organ procurement-based tissue bank, will supply donated allograft skin tissue to LIFC for processing into cryopreserved skin and LIFC's Alloderm graftable tissue to treat burn victims. LifeCell Corp. (LIFC), Branchburg, N.J.   LifeNet,...